Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.510
+0.170 (7.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Context Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -36.12 | -26.73 | -23.96 | -14.84 | -10.46 | |
| Depreciation & Amortization | 0.02 | 0.01 | 0.01 | 0.01 | - | |
| Asset Writedown & Restructuring Costs | 2 | 14.75 | - | 0.58 | 3.09 | |
| Stock-Based Compensation | 1.33 | 0.84 | 1.08 | 0.98 | 0.51 | |
| Other Operating Activities | 0.11 | 0.04 | 0.05 | - | 0.28 | |
| Change in Accounts Payable | 1.1 | -0.95 | 1.45 | -0.79 | -0.87 | |
| Change in Other Net Operating Assets | 5.19 | -2.53 | 0.33 | 0.51 | -1.36 | |
| Operating Cash Flow | -26.39 | -14.56 | -21.05 | -13.55 | -8.8 | |
| Capital Expenditures | -0.03 | -0.01 | - | -0.04 | - | |
| Sale (Purchase) of Intangibles | -2 | -14.75 | - | -0.5 | -0.25 | |
| Investing Cash Flow | -2.03 | -14.76 | - | -0.54 | -0.25 | |
| Issuance of Common Stock | - | 109.29 | - | - | 53.41 | |
| Other Financing Activities | -0.02 | - | - | -0.1 | - | |
| Financing Cash Flow | -0.02 | 109.29 | - | -0.1 | 58.39 | |
| Net Cash Flow | -28.43 | 79.98 | -21.05 | -14.19 | 49.34 | |
| Free Cash Flow | -26.42 | -14.56 | -21.05 | -13.59 | -8.8 | |
| Free Cash Flow Per Share | -0.28 | -0.25 | -1.32 | -0.85 | -3.10 | |
| Levered Free Cash Flow | -19.13 | -36.03 | -12.78 | -9.47 | -6.67 | |
| Unlevered Free Cash Flow | -19.13 | -36.03 | -12.78 | -9.47 | -6.63 | |
| Change in Working Capital | 6.28 | -3.48 | 1.78 | -0.28 | -2.22 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.